论著

甘肃省棘球蚴病定点医院棘球蚴病手术患者住院费用影响因素分析

  • 徐丹 ,
  • 严俊 ,
  • 闫欢 ,
  • 贺洪峰 ,
  • 梁天虎 ,
  • 赵俊贤 ,
  • 陈耀龙 ,
  • 李汛
展开
  • 1 兰州大学第一医院临床医学研究中心,甘肃 兰州 730000
    2 兰州大学第一医院普通外科国家临床重点专科,甘肃 兰州 730000
    3 兰州大学第一医院甘肃省普通外科临床医学研究中心,甘肃 兰州 730000
    4 甘肃省生物治疗与再生医学重点实验室,甘肃 兰州 730000
    5 兰州大学第一医院骨科一病区,甘肃 兰州 730000
    6 兰州大学公共卫生学院,甘肃 兰州 730000
徐丹(1991—),女,本科,护师,从事棘球蚴病管理工作。E-mail:xudan0312@163.com
*李汛(1972—),男,博士,主任医师,从事肝胆胰外科工作。E-mail:lxdr21@126.com

收稿日期: 2024-04-09

  修回日期: 2024-06-30

  网络出版日期: 2024-08-21

基金资助

甘肃省卫生健康行业科研计划(GSWSHL2021-019)

Analysis on influencing factors of hospitalization costs of echinococcosis surgery patients in designated echinococcosis hospital in Gansu Province

  • XU Dan ,
  • YAN Jun ,
  • YAN Huan ,
  • HE Hongfeng ,
  • LIANG Tianhu ,
  • ZHAO Junxian ,
  • CHEN Yaolong ,
  • LI Xun
Expand
  • 1 Research Center for Clinical Medicine, the First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China
    2 National Clinical Key Specialty of General Surgery of the First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China
    3 Gansu Clinical Medical Research Center of General Surgery, the First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China
    4 Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou 730000, Gansu, China
    5 Department of Orthopedics, the First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China
    6 School of Public Health, Lanzhou University, Lanzhou 730000, Gansu, China

Received date: 2024-04-09

  Revised date: 2024-06-30

  Online published: 2024-08-21

Supported by

Gansu Province Health Industry Scientific Research Project(GSWSHL2021-019)

摘要

目的 分析甘肃省级棘球蚴病定点医院棘球蚴病手术患者的住院费用及其影响因素,为有效控制棘球蚴病医疗费用提供依据。 方法 收集甘肃省级棘球蚴病定点医院2014年1月—2023年12月行外科手术的棘球蚴病患者资料,包括患者基本资料(住院年份、性别、职业、年龄、医保类型、民族)、临床资料(入院途径、是否转科、住院时间、棘球蚴病类型、疾病转归、有无并发症、棘球蚴寄生部位、手术方式)和住院费用资料(住院总费用、手术费用、西药费用、耗材费用、诊断费用、其他费用)。采用SPSS 29.0统计软件进行数据分析,住院费用用中位数表示,单因素分析中非正态分布数据两组间比较使用Mann-Whitney U检验、多组间比较使用Kruskal-Wallis H检验,多因素分析采用多元线性回归方法。 结果 共收集540例棘球蚴病手术患者资料,其中细粒棘球蚴病患者504例,多房棘球蚴病患者36例;女性280例,男性260例。住院总费用合计2 080.98万元,人均住院费用38 528.41元,住院费用中位数为33 732.87元。棘球蚴病患者人均住院费用从2014年的31 276.59元上升至2023年的45 902.34元。男、女住院费用中位数分别为35 232.35、31 891.16元,二者差异有统计学意义(Z = -2.343,P < 0.05);≥ 61岁患者住院费用中位数最高,为35 233.75元,不同年龄间住院费用差异有统计学意义(P < 0.05);个体患者住院费用中位数最高,为39 843.04元,不同职业住院费用差异有统计学意义(P < 0.05);东乡族患者住院费用中位数最高,为65 401.29元,不同民族住院费用差异有统计学意义(P < 0.05);转入ICU患者住院费用中位数为62 720.04元,高于未转科患者的32 526.89元(Z = -7.440,P < 0.05);住院时间≥ 21 d患者住院费用中位数最高,为54 433.71元,不同住院时间住院费用差异有统计学意义(P < 0.05);多房棘球蚴病患者住院费用中位数为43 949.85元,高于细粒棘球蚴病患者的33 555.82元(Z = -3.317,P < 0.05);转院患者住院费用中位数最高,为104 536.50元,不同类型疾病转归患者住院费用差异有统计学意义(P < 0.05);有并发症患者住院费用中位数为46 855.89元,高于无并发症患者的32 476.43元(Z = -6.060,P < 0.05);肝脏棘球蚴病患者住院费用中位数为32 433.02元,低于多脏器棘球蚴病患者的43 550.83元(Z = -4.933,P < 0.05);行肝移植患者住院费用中位数最高,为170 030.84元,不同手术方式住院费用差异有统计学意义(P < 0.05)。多元线性回归分析结果显示,棘球蚴病手术患者住院费用主要影响因素为年份(t = 5.937,P < 0.01)、年龄(t = 3.349,P < 0.01)、职业(t = 2.238,P < 0.05)、是否转科(t = 8.778,P < 0.01)、住院时间(t = 7.346,P < 0.01)、棘球蚴病类型(t = 6.049,P < 0.01)、有无并发症(t = 5.967,P < 0.01)、棘球蚴寄生部位(t = 3.767,P < 0.01)。 结论 2014—2023年甘肃省级棘球蚴病定点医院棘球蚴病手术患者人均住院费用逐年上升,年份、年龄、职业、是否转科、住院时间、棘球蚴病类型、有无并发症、棘球蚴寄生部位等是影响住院费用的主要因素。

本文引用格式

徐丹 , 严俊 , 闫欢 , 贺洪峰 , 梁天虎 , 赵俊贤 , 陈耀龙 , 李汛 . 甘肃省棘球蚴病定点医院棘球蚴病手术患者住院费用影响因素分析[J]. 中国寄生虫学与寄生虫病杂志, 2024 , 42(4) : 461 -468 . DOI: 10.12140/j.issn.1000-7423.2024.04.006

Abstract

Objective To analyze the hospitalization cost of echinococcosis surgery patients and its influencing factors in Gansu provincial designated echinococcosis hospital, and to provide basis for effieicent management of the medical cost for echinococcosis. Methods Data of echinococcosis patients who underwent surgery at provincial designated hospital in Gansu Province from January 2014 to December 2023 were collected. The data included patients’ basic information (hospitalization year, gender, occupation, age, medical insurance type, ethnicity), clinical information (admission pathway, whether transferred from another department, length of hospital stay, type of echinococcosis, disease outcome, presence of complications, location of cyst, type of surgery), and hospitalization cost data (total hospitalization cost, surgery cost, western medicine cost, consumables cost, diagnostic cost, other costs). Data analysis was conducted using the SPSS 29.0 statistical software. Median was used to represent the hospitalization cost. In single factor analysis, Mann-Whitney U test was used for comparison between two groups, and Kruskal-Wallis H test for comparison among multiple groups for non normal distribution data. Multivariate analysis was performed using multiple linear regression. Results A total of 540 echinococcosis surgery patients’ data were collected, including 504 patients with cystic echinococcosis and 36 patients with alveolar echinococcosis; 280 females and 260 males, with a total combined hospitalization cost of 20 809 800 yuan, a per capita hospitalization cost of 38 528.41 yuan, and median hospitalization cost of 33 732.87 yuan. In 2014 versus 2023, the hospitalization costs for patients with echinococcosis per capita increased from 31 276.59 yuan to 45 902.34 yuan. The median hospitalization costs for male and female cases were 35 232.35 and 31 891.16 yuan, respectively, and the difference was statistically significant (Z = -2.343, P < 0.05); the median hospitalization cost for patients ≥ 61 years old was the highest, 35 233.75 yuan, and the cost difference between different ages was statistically significant (P < 0.05); the median hospitalization cost for individual patients was the highest, 39 843.04 yuan, and the difference in hospitalization costs between different occupations was statistically significant (P < 0.05); the median hospitalization cost for Dongxiang patients was the highest at 65 401.29 yuan, and the difference in hospitalization costs between different ethnic groups was statistically significant (P < 0.05); the median hospitalization cost for patients transferred to ICU was 62 720.04 yuan, higher than the 32 526.89 yuan for patients who were not transferred to the department, and the difference was statistically significant (Z = -7.440, P < 0.05); the median hospitalization cost of patients with hospitalization time ≥ 21 d was the highest at 54 433.71 yuan, and the difference in hospitalization cost between different hospitalization times was statistically significant (P < 0.05); the median hospitalization cost of patients with multilocular echinococcosis was 43 949.85 yuan, higher than that of patients with fine-grained echinococcosis at 33 555.82 yuan (Z = -3.317, P < 0.05); the median hospitalization cost of transferred patients was the highest at 104 536.50 yuan, and the difference in hospitalization costs for different types of disease transfer was statistically significant (P < 0.05); the median hospitalization cost among patients with complications was 46 855.89 yuan, higher than that of 32 476.43 yuan for patients without complications (Z = -6.060, P < 0.05); the median hospitalization cost of patients with hepatic echinococcosis was 32 433.02 yuan, which was lower than that of patients with multi-organ echinococcosis, which was 43 550.83 yuan (Z = -4.933, P < 0.05); the median hospitalization cost of patients who underwent liver transplantation was the highest, which was 170 030.84 yuan, and the difference in hospitalization costs between different surgical procedures was statistically significant (P < 0.05). The results of multivariate linear regression analysis showed that the main factors influencing the cost of hospitalization for patients undergoing surgery for echinococcosis were year of hospitalization (t = 5.937, P < 0.01), age (t = 3.349, P < 0.01), occupation (t = 2.238, P < 0.05), whether or not to transfer to a different department (t = 8.778, P < 0.01), length of hospitalization (t = 7.346, P < 0.01), type of echinococcosis (t = 6.049, P < 0.01), the presence or absence of complications (t = 5.967, P < 0.01), location of cyst (t = 3.767, P < 0.01). Conclusion The per capita hospitalization cost of echinococcosis surgery patients in provincial designated hospital increased year by year from 2014 to 2023, The main factors influencing of hospitalization costs include year, age, occupation, whether or not to transfer to a different department, length of hospitalization, type of echinococcosis, the presence or absence of complications and location of cyst.

参考文献

[1] Wang TP, Cao ZG. Current status of echinococcosis control in China and the existing challenges[J]. Chin J Parasitol Parasit Dis, 2018, 36(3): 291-296. (in Chinese)
  (汪天平, 操治国. 中国棘球蚴病防控进展及其存在的问题[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(3): 291-296.)
[2] Yu DW, Ding GW, Hou YD, et al. Clustering analysis of hydatid disease in Gansu Province[J]. Chin J Parasitol Parasit Dis, 2015, 33(4): 280-282. (in Chinese)
  (余大为, 丁国武, 侯言东, 等. 甘肃省细粒棘球蚴病聚类分析[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(4): 280-282.)
[3] Ailiyali AL, Sun L, Li BL, et al. The economic burden of echinococcosis in China: a systematic review[J]. Chin J Evid Based Med, 2019, 19(12): 1416-1422. (in Chinese)
  (艾力亚力?艾力, 孙立, 李波霖, 等. 中国包虫病患者经济负担研究的系统评价[J]. 中国循证医学杂志, 2019, 19(12): 1416-1422.)
[4] Zhang MY, Wu WP. Advances in study of the burden of echinococcosis in China and elsewhere around the world[J]. J Pathog Biol, 2017, 12(5): 473-475. (in Chinese)
  (张梦媛, 伍卫平. 国内外包虫病疾病负担研究进展[J]. 中国病原生物学杂志, 2017, 12(5): 473-475.)
[5] Zhu YY, Wu WP. Advances in echinococcosis prevention and control programs and research in China and elsewhere around the world[J]. J Pathog Biol, 2016, 2(3): 284-286, Ⅰ0001. (in Chinese)
  (朱曜宇, 伍卫平. 国内外包虫病防治和研究进展[J]. 中国病原生物学杂志, 2016, 2(3): 284-286, Ⅰ0001.)
[6] Zhang MY, Wu WP, Guan YY, et al. Analysis on disease burden of hydatid disease in China[J]. Chin J Parasitol Parasit Dis, 2018, 4(1): 15-19, 25. (in Chinese)
  (张梦媛, 伍卫平, 官亚宜, 等. 我国棘球蚴病疾病负担分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 4(1): 15-19, 25.)
[7] Chen HG, Wang TW, Han J, et al. Major disease-specific hospitalizations and their expenses among rural residents covered by NRCMS in Yulin city of Shaanxi Province[J]. Chin J Public Health, 2020, 36(1): 115-119. (in Chinese)
  (陈红光, 王廷伟, 韩晶, 等. 农村重大疾病流行特征及其住院医疗费用分析[J]. 中国公共卫生, 2020, 36(1): 115-119.)
[8] Du HJ, Zheng EW. Analysis on the influencing factors of hospitalization expenses of diabetic patients[J]. Chin Med Rec, 2022, 23(5): 45-48. (in Chinese)
  (杜慧杰, 郑二维. 糖尿病患者住院费用影响因素分析[J]. 中国病案, 2022, 23(5): 45-48.)
[9] Zhang X, Wang JH, Yin H, et al. Medical expense of hospitalization among inpatients with major non-communicable chronic diseases in China, 2013[J]. Chin J Public Health, 2021, 37(4): 615-617. (in Chinese)
  (张鑫, 王佳慧, 尹航, 等. 中国2013年主要慢性病患者住院费用分析[J]. 中国公共卫生, 2021, 37(4): 615-617.)
[10] Ministry of Health of the People’s Republic of China. Diagnostic criteria for echinococcosis: WS 257-2006[S]. Beijing: People’s Medical Publishing House, 2006: 1-11. (in Chinese)
  (中华人民共和国卫生部. 包虫病诊断标准: WS 257—2006[S]. 北京: 人民卫生出版社, 2006: 1-11.)
[11] General Office of the State Council. Circular of the General Office of the State Council on the issuance of the 14th Five-Year Plan for universal medical security[EB/OL]. (2021-09-23)[2024-03-08]. https://www.nhsa.gov.cn/art/2021/9/29/art_37_6137.html. (in Chinese)
  (国务院办公厅. 国务院办公厅关于印发“十四五”全民医疗保障规划的通知[EB/OL]. (2021-09-23)[2024-03-08]. https://www.nhsa.gov.cn/art/2021/9/29/art_37_6137.html.)
[12] National Health and Health Commission. 2022 China health and health statistics yearbook[EB/OL]. (2023-05-17)[2024-03-08]. http://www.nhc.gov.cn/mohwsbwstjxxzx/tjtjnj/202305/6ef68aac-6bd14c1eb9375e01a0faa1fb.shtml. (in Chinese)
  (国家卫生健康委员会. 2022中国卫生健康统计年鉴[EB/OL]. (2023-05-17)[2024-03-08]. http://www.nhc.gov.cn/mohwsbwstjxxzx/tjtjnj/202305/6ef68aac6bd14c1eb9375e01a0faa1fb.shtml.)
[13] Shao J, Wang ZX, Yang DCR, et al. Analysis of influencing factors on hospitalization expenditures of patients with alveolar echinococcosis in Qinghai-Tibet Plateau[J]. Chin J Dis Control Prev, 2018, 4(2): 168-172.
  in Chinese (邵军, 王志鑫, 阳丹才让, 等. 青藏高原地区泡型包虫病患 者住院费用影响因素分析[J]. 中华疾病控制杂志, 2018, 4(2): 168-172.
[14] Chen YY, Ma RL, Guo H, et al. Prevalence and influencing factors of chronic diseases and chronic multimorbidity among Uygur rural adults: a cross-sectional survey in Xinjiang Production and Construction Corps[J]. Chin J Public Health, 2023, 39(11): 1376-1382. (in Chinese)
  (陈姚姚, 马儒林, 郭恒, 等. 新疆维吾尔族农村居民慢性病和慢性病共病患病情况及其影响因素分析[J]. 中国公共卫生, 2023, 39(11): 1376-1382.)
[15] National Health Commission. Measures on the management of centralized transfer payments to local projects for the treatment of patients suffering from Baobab disease[EB/OL]. (2020-08-31)[2024-03-08]. https://www.gov.cn/zhengce/zhengceku/2020-09/03/content_5539743.htm. (in Chinese)
  (国家卫生健康委员会. 中央转移支付地方项目包虫病患者救治管理办法[EB/OL]. (2020-08-31)[2024-03-08]. https://www.gov.cn/zhengce/zhengceku/2020-09/03/content_5539743.htm.)
[16] Wang L, Alimu AL Yao H. Analysis of influencing factors of the direct medical costs of 1 958 patients with hydatid disease[J]. Chin Prev Med, 2017, 3(8): 601-604. (in Chinese)
  (王乐, 阿力木?艾力, 姚华. 1 958例包虫病患者直接医疗费用影响因素分析[J]. 中国预防医学杂志, 2017, 3(8): 601-604.)
[17] Duan XY, Wei JJ, Wang L, et al. Direct economic burden of inpatients with echinococcosis in primary hospitals in Xinjiang[J]. Pract Prev Med, 2015, 22(10): 1164-1166. (in Chinese)
  (段新宇, 魏晶晶, 王乐, 等. 新疆基层医院包虫病住院患者直接经济负担分析[J]. 实用预防医学, 2015, 22(10): 1164-1166.)
[18] Gao C. Analysis of hospitalization expenses and influencing factors of 952 patients with echinococcosis from 2012 to 2016[D]. Xining: Qinghai University, 2017: 42. (in Chinese)
  (高超. 2012—2016年952例包虫病患者住院费用及影响因素分析[D]. 西宁: 青海大学, 2017: 42.)
[19] Si Q, Liu CH, Shao YM, et al. Influencing factors analysis on the hospitalization cost of 2 064 cases of patients with echinococcosis[J]. Chin Med Rec, 2016, 2(5): 52-54. (in Chinese)
  (斯琴, 刘才华, 邵英梅, 等. 2 064例包虫病患者住院费用影响因素分析[J]. 中国病案, 2016, 2(5): 52-54.)
[20] Ding Y, Duan XY, Wang L, et al. Study on economic burden of echinococcosis patients in designated hospitals in Xinjiang[J]. Chin J Health Stat, 2013, 30(2): 240-241. (in Chinese)
  (丁艳, 段新宇, 王乐, 等. 新疆包虫病定点医院包虫病患者经济负担研究[J]. 中国卫生统计, 2013, 30(2): 240-241.)
[21] Duan HJ, Li LJ, Wu XL, et al. Analysis of hospitalization expenses and influencing factors in surgery for patients with cystic echinococcosis in Ningxia during 2016-2021[J]. Chin J Parasitol Parasit Dis, 2023, 41(1): 75-80, 84. (in Chinese)
  (段红菊, 李凌杰, 吴向林, 等. 2016—2021年宁夏细粒棘球蚴病手术患者住院费用及其影响因素分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(1): 75-80, 84.)
[22] Zulifeiye AZZ. Study on economic burden of patients with end-stage hepatic alveolar echinococcosis treated by autologous liver transplantation[D]. Urumqi: Xinjiang Medical University, 2017: 26-27. (in Chinese)
  (祖丽菲耶?艾则孜. 自体肝移植治疗终末期肝泡型包虫病患者疾病经济负担研究[D]. 乌鲁木齐: 新疆医科大学, 2017:26-27.)
[23] Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation[J]. Br J Anaesth, 1997, 78(5): 606-617.)
[24] Kui Y, Xue CZ, Wang X, et al. Progress of echinococcosis control in China, 2022[J]. Chin J Parasitol Parasit Dis, 2024, 10(1): 8-16. (in Chinese)
  (蒉嫣, 薛垂召, 王旭, 等. 2022年全国棘球蚴病防治工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2024, 10(1): 8-16.)
[25] Li QY. Analysis on influencing factors of hospitalization expenses of cystic echinococcosis patients in Qinghai Province[J]. Chongqing Med, 2018, 47(33): 4310-4312. (in Chinese)
  (李全元. 青海省囊型包虫病患者住院费用影响因素分析[J]. 重庆医学, 2018, 47(33): 4310-4312.)
[26] Qi XH, Li BL, Yin XF, et al. Analysis of influencing factors for hospitalization and related expenses for hydatid patients receiving surgical treatment in Xinjiang[J]. Chin J Parasitol Parasit Dis, 2018, 36(2): 196-198. (in Chinese)
  (齐新红, 李波霖, 殷雪峰, 等. 新疆棘球蚴病外科救助患者住院及相关费用影响因素分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(2): 196-198.)
[27] Ma FR. Analysis of hospitalization expenses and influencing factors of echinococcosis patients in Xinjiang production and construction corps[D]. Shihezi: Shihezi University, 2013: 35. (in Chinese)
  (马芙蓉. 新疆生产建设兵团包虫病患者住院费用及影响因素分析[D]. 石河子: 石河子大学, 2013: 35.)
[28] Yao RX, Zhong B, Wang Q, et al. Analysis of hospitalization expenses and subsidies for echinococcosis patients in Sichuan Province during 2016-2020[J]. Chin J Parasitol Parasit Dis, 2021, 39(2): 161-165. (in Chinese)
  (姚人新, 钟波, 王谦, 等. 2016—2020年四川省504例棘球蚴病患者住院费用及补助情况分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 161-165.)
文章导航

/

〈 〉